Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 184,508 | 176,093 | 145,201 | 147,816 | 95,229 |
| Marketable Securities | 114,037 | 131,449 | 190,612 | 206,090 | 200,753 |
| Receivables | 36,521 | 10,536 | 16,830 | 10,371 | 43,102 |
| Inventories | 2,904 | 2,837 | 3,746 | 3,087 | 3,229 |
| TOTAL | $341,392 | $324,958 | $359,312 | $369,854 | $343,955 |
| Non-Current Assets | |||||
| PPE Net | 60,535 | 64,044 | 67,366 | 69,055 | 71,239 |
| Investments And Advances | 18,109 | 26,020 | 15,798 | 26,622 | 52,930 |
| Other Non-Current Assets | 3,465 | 4,253 | 4,472 | 4,761 | 4,984 |
| TOTAL | $82,109 | $94,317 | $87,636 | $100,438 | $129,153 |
| Total Assets | $423,501 | $419,275 | $446,948 | $470,292 | $473,108 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,337 | 20,599 | 17,043 | 17,468 | 18,872 |
| TOTAL | $40,357 | $33,521 | $29,949 | $29,931 | $34,139 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 |
| Deferred Revenues | 17,020 | 12,922 | 12,906 | 12,463 | 15,267 |
| TOTAL | $269,142 | $249,373 | $251,939 | $254,577 | $256,426 |
| Total Liabilities | $309,499 | $282,894 | $281,888 | $284,508 | $290,565 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,859 | 56,163 | 56,126 | 56,121 | 56,122 |
| Common Shares | 56 | 56 | 56 | 56 | 56 |
| Retained earnings | -585,280 | -555,608 | -520,956 | -493,957 | -489,834 |
| Other shareholders' equity | -785 | -1,493 | -2,005 | -2,893 | -3,068 |
| TOTAL | $114,002 | $136,381 | $165,060 | $185,784 | $182,543 |
| Total Liabilities And Equity | $423,501 | $419,275 | $446,948 | $470,292 | $473,108 |